Cloudbreak Pharma Inc.（联交所股票代码：02592）于2026年3月2日发布截至2026年2月28日的证券变动月报。报告显示，本月公司已发行股本及库藏股数量均未发生增减。
\n\n公司法定注册股本维持在2,000,000,000股普通股，面值每股0.0001美元，法定注册股本合计200,000美元。截至2月28日，已发行股份数为850,122,081股，库藏股份为0股，均与上月底保持一致，期间未有新增发行或购回注销活动。
\n\n月报同时列明了公司多项股权激励安排，包括系列B和系列C股权激励、2023年股权激励计划以及首次公开发售后股权激励计划。本月内，各相关计划项下均无新股发行、期权行使或库藏股转让行为，潜在可发行或转让股份数量保持不变。
\n\n公司确认，已符合相应的公众持股量要求，并遵守香港联合交易所有限公司《上市规则》及相关法律规定。公告由公司秘书冯雅芳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.